KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Research & Development (2016 - 2025)

Historic Research & Development for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $191.5 million.

  • Exact Sciences' Research & Development rose 9598.5% to $191.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $523.0 million, marking a year-over-year increase of 2128.57%. This contributed to the annual value of $523.0 million for FY2025, which is 2128.57% up from last year.
  • As of Q4 2025, Exact Sciences' Research & Development stood at $191.5 million, which was up 9598.5% from $117.3 million recorded in Q3 2025.
  • Exact Sciences' Research & Development's 5-year high stood at $191.5 million during Q4 2025, with a 5-year trough of $75.4 million in Q3 2021.
  • Over the past 5 years, Exact Sciences' median Research & Development value was $105.7 million (recorded in 2022), while the average stood at $108.0 million.
  • Examining YoY changes over the last 5 years, Exact Sciences' Research & Development showed a top increase of 22514.61% in 2021 and a maximum decrease of 8017.95% in 2021.
  • Exact Sciences' Research & Development (Quarter) stood at $88.5 million in 2021, then rose by 7.41% to $95.0 million in 2022, then rose by 21.19% to $115.2 million in 2023, then decreased by 15.17% to $97.7 million in 2024, then soared by 95.99% to $191.5 million in 2025.
  • Its last three reported values are $191.5 million in Q4 2025, $117.3 million for Q3 2025, and $108.9 million during Q2 2025.